McMaster University

McMaster University

Faculty of
Health Sciences

Leading thrombosis expert appointed to new Jack Hirsh Professorship

Published: April 24, 2014
Clive Kearon
Clive Kearon, professor, Department of Medicine

It is fitting that Clive Kearon, a professor of medicine at McMaster University and program director of its Clinical Investigator Program, has been appointed as the inaugural holder of the Jack Hirsh Professorship in Thrombosis.

"Dr. Jack Hirsh has been one of my most important research mentors, as well as being an internationally acknowledged 'giant' in the field of clinical thromboembolism," says Kearon. "It is especially pleasing for me to be linked to his name and reputation."

Named after Dr. Jack Hirsh, professor emeritus in the Department of Medicine at McMaster, the prestigious position is endowed with funding from the Department of Medicine as well as annual matching funds from the Thrombosis & Atherosclerosis Research Institute (TaARI).

Hirsh said he was delighted to learn about the position for two reasons. "The first, because I am honored to have a Professorship in my name, and the second is because I am so pleased that the inaugural recipient is Clive Kearon. Clive became a member of the thrombosis group after training in respiratory medicine. When I first interviewed him, I had no idea that he would become so successful. Through his research, Clive has made highly innovative and important contributions to patient care. He is recognized and respected internationally and his appointment brings great credit to the Hirsh Professorship."

Adds John Kelton, dean and vice-president of the Faculty of Health Sciences: "Dr. Kearon is an exceptional researcher who has made significant contributions in the area of thrombosis through teaching, research and clinical work and is highly deserving of this honour."

Kearon's clinical responsibilities primarily focus on the management of thromboembolic disorders.  He was a career investigator of the Canadian Institutes of Health Research and is now an investigator of the Heart and Stroke Foundation of Canada.  He is the recipient of two awards from the Canadian Institutes of Health Research for providing mentorship in the design and conduct of randomized controlled trials, and the recipient of the International Society on Thrombosis and Haemostasis' 14th Biennial Investigator Recognition Award.

He is involved in the critical appraisal of the medical literature, the development of practice guidelines, and is lead author for the current American College of Chest Physicians' guidelines for the treatment of venous thromboembolism.

Hirsh was the founding director of the Henderson Research Centre, and is a former Chair of McMaster's Department of Medicine. He established a thrombosis program at McMaster that has been pre-eminent in thrombosis research for more than three decades and has trained many scientists who now head up thrombosis units throughout the world. He was a founding senior scientist and vice-president of research of Vascular Therapeutics Inc.

His studies contributed to the discovery of unique characteristics of low-molecular-weight heparin and led eventually to the identification of its potential clinical advantages.

Says Kearon: "Dr. Hirsh has been a source of inspiration for all of us who work in this area of research, and I will do my best to live up to his example and do this prestigious position proud."

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0